[Preventative and therapeutic relapse strategies after allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)]. [electronic resource]
- Bulletin du cancer Dec 2017
- S84-S98 p. digital
Publication Type: Journal Article; Practice Guideline; Review
1769-6917
10.1016/j.bulcan.2017.05.009 doi
Antineoplastic Agents--therapeutic use Bortezomib--therapeutic use Central Nervous System Neoplasms--prevention & control Genetic Markers Hematologic Neoplasms--genetics Hematopoietic Stem Cell Transplantation Humans Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy Lymphoma--drug therapy Maintenance Chemotherapy--standards Multiple Myeloma--drug therapy Neoplasm, Residual Prognosis Protein Kinase Inhibitors--therapeutic use Recurrence Retreatment--methods Secondary Prevention--methods